vs

Side-by-side financial comparison of Community Healthcare Trust Inc (CHCT) and SYPRIS SOLUTIONS INC (SYPR). Click either name above to swap in a different company.

Community Healthcare Trust Inc is the larger business by last-quarter revenue ($30.9M vs $30.3M, roughly 1.0× SYPRIS SOLUTIONS INC). Community Healthcare Trust Inc runs the higher net margin — 46.6% vs -12.9%, a 59.5% gap on every dollar of revenue. On growth, Community Healthcare Trust Inc posted the faster year-over-year revenue change (5.6% vs -9.5%). Community Healthcare Trust Inc produced more free cash flow last quarter ($35.9M vs $-1.5M). Over the past eight quarters, Community Healthcare Trust Inc's revenue compounded faster (2.7% CAGR vs -7.7%).

Medical Properties Trust, Inc. (MPT) is an international real estate investment trust (REIT) based in Birmingham, Alabama that purchases and invests in healthcare facilities and for-profit healthcare holding companies, primarily in the United States and Europe. Their property acquisitions often come in the form of sale-leaseback agreements, in which the original property owner sells the property to MPT and becomes their tenant. MPT's tenants are generally subject to long-term triple net lease...

Sypris Solutions Inc. is a U.S.-headquartered provider of highly engineered components and specialized technical services, primarily serving aerospace, defense, automotive and commercial industrial markets. It delivers custom manufacturing, performance testing, and value-added engineering support for mission-critical systems and parts for global enterprise clients.

CHCT vs SYPR — Head-to-Head

Bigger by revenue
CHCT
CHCT
1.0× larger
CHCT
$30.9M
$30.3M
SYPR
Growing faster (revenue YoY)
CHCT
CHCT
+15.1% gap
CHCT
5.6%
-9.5%
SYPR
Higher net margin
CHCT
CHCT
59.5% more per $
CHCT
46.6%
-12.9%
SYPR
More free cash flow
CHCT
CHCT
$37.4M more FCF
CHCT
$35.9M
$-1.5M
SYPR
Faster 2-yr revenue CAGR
CHCT
CHCT
Annualised
CHCT
2.7%
-7.7%
SYPR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CHCT
CHCT
SYPR
SYPR
Revenue
$30.9M
$30.3M
Net Profit
$14.4M
$-3.9M
Gross Margin
4.6%
Operating Margin
-10.9%
Net Margin
46.6%
-12.9%
Revenue YoY
5.6%
-9.5%
Net Profit YoY
687.6%
-2992.6%
EPS (diluted)
$0.52
$-0.17

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CHCT
CHCT
SYPR
SYPR
Q4 25
$30.9M
$30.3M
Q3 25
$31.1M
$28.7M
Q2 25
$29.1M
$31.4M
Q1 25
$30.1M
$29.5M
Q4 24
$29.3M
$33.4M
Q3 24
$29.6M
$35.7M
Q2 24
$27.5M
$35.5M
Q1 24
$29.3M
$35.6M
Net Profit
CHCT
CHCT
SYPR
SYPR
Q4 25
$14.4M
$-3.9M
Q3 25
$1.6M
$517.0K
Q2 25
$-12.6M
$-2.1M
Q1 25
$1.6M
$-899.0K
Q4 24
$1.8M
$135.0K
Q3 24
$1.7M
$390.0K
Q2 24
$-10.4M
$16.0K
Q1 24
$3.7M
$-2.2M
Gross Margin
CHCT
CHCT
SYPR
SYPR
Q4 25
4.6%
Q3 25
7.2%
Q2 25
8.2%
Q1 25
11.4%
Q4 24
16.1%
Q3 24
16.8%
Q2 24
15.9%
Q1 24
8.1%
Operating Margin
CHCT
CHCT
SYPR
SYPR
Q4 25
-10.9%
Q3 25
-6.1%
Q2 25
-4.6%
Q1 25
-0.4%
Q4 24
3.9%
Q3 24
4.8%
Q2 24
3.6%
Q1 24
-3.9%
Net Margin
CHCT
CHCT
SYPR
SYPR
Q4 25
46.6%
-12.9%
Q3 25
5.3%
1.8%
Q2 25
-43.2%
-6.5%
Q1 25
5.3%
-3.0%
Q4 24
6.3%
0.4%
Q3 24
5.9%
1.1%
Q2 24
-37.9%
0.0%
Q1 24
12.5%
-6.2%
EPS (diluted)
CHCT
CHCT
SYPR
SYPR
Q4 25
$0.52
$-0.17
Q3 25
$0.03
$0.02
Q2 25
$-0.50
$-0.09
Q1 25
$0.03
$-0.04
Q4 24
$0.04
$0.00
Q3 24
$0.04
$0.02
Q2 24
$-0.42
$0.00
Q1 24
$0.11
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CHCT
CHCT
SYPR
SYPR
Cash + ST InvestmentsLiquidity on hand
$3.3M
Total DebtLower is stronger
$532.2M
Stockholders' EquityBook value
$429.4M
$17.8M
Total Assets
$990.8M
$107.8M
Debt / EquityLower = less leverage
1.24×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CHCT
CHCT
SYPR
SYPR
Q4 25
$3.3M
Q3 25
$3.4M
Q2 25
$4.9M
Q1 25
$2.3M
Q4 24
$4.4M
Q3 24
$2.8M
Q2 24
$734.0K
Q1 24
$3.8M
Total Debt
CHCT
CHCT
SYPR
SYPR
Q4 25
$532.2M
Q3 25
$530.1M
Q2 25
$500.1M
Q1 25
$496.0M
Q4 24
$486.0M
Q3 24
$473.7M
Q2 24
$457.6M
Q1 24
$442.3M
Stockholders' Equity
CHCT
CHCT
SYPR
SYPR
Q4 25
$429.4M
$17.8M
Q3 25
$426.8M
$20.0M
Q2 25
$437.8M
$18.7M
Q1 25
$461.3M
$19.0M
Q4 24
$476.0M
$19.6M
Q3 24
$477.2M
$18.2M
Q2 24
$497.8M
$19.0M
Q1 24
$511.6M
$20.8M
Total Assets
CHCT
CHCT
SYPR
SYPR
Q4 25
$990.8M
$107.8M
Q3 25
$987.3M
$112.5M
Q2 25
$966.3M
$105.8M
Q1 25
$985.1M
$110.2M
Q4 24
$992.6M
$119.4M
Q3 24
$981.8M
$121.6M
Q2 24
$983.2M
$124.2M
Q1 24
$982.7M
$129.0M
Debt / Equity
CHCT
CHCT
SYPR
SYPR
Q4 25
1.24×
Q3 25
1.24×
Q2 25
1.14×
Q1 25
1.08×
Q4 24
1.02×
Q3 24
0.99×
Q2 24
0.92×
Q1 24
0.86×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CHCT
CHCT
SYPR
SYPR
Operating Cash FlowLast quarter
$56.4M
$-1.1M
Free Cash FlowOCF − Capex
$35.9M
$-1.5M
FCF MarginFCF / Revenue
116.0%
-5.0%
Capex IntensityCapex / Revenue
66.3%
1.3%
Cash ConversionOCF / Net Profit
3.91×
TTM Free Cash FlowTrailing 4 quarters
$62.8M
$-6.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CHCT
CHCT
SYPR
SYPR
Q4 25
$56.4M
$-1.1M
Q3 25
$12.7M
$-178.0K
Q2 25
$13.8M
$1.1M
Q1 25
$14.4M
$-5.5M
Q4 24
$58.9M
$2.3M
Q3 24
$13.8M
$-4.8M
Q2 24
$16.7M
$6.2M
Q1 24
$12.6M
$-1.7M
Free Cash Flow
CHCT
CHCT
SYPR
SYPR
Q4 25
$35.9M
$-1.5M
Q3 25
$7.6M
$-390.0K
Q2 25
$9.6M
$941.0K
Q1 25
$9.7M
$-5.5M
Q4 24
$34.2M
$1.9M
Q3 24
$6.7M
$-4.9M
Q2 24
$9.5M
$6.0M
Q1 24
$7.5M
$-2.0M
FCF Margin
CHCT
CHCT
SYPR
SYPR
Q4 25
116.0%
-5.0%
Q3 25
24.6%
-1.4%
Q2 25
32.9%
3.0%
Q1 25
32.3%
-18.8%
Q4 24
116.9%
5.7%
Q3 24
22.5%
-13.8%
Q2 24
34.7%
16.8%
Q1 24
25.7%
-5.7%
Capex Intensity
CHCT
CHCT
SYPR
SYPR
Q4 25
66.3%
1.3%
Q3 25
16.3%
0.7%
Q2 25
14.5%
0.5%
Q1 25
15.6%
0.0%
Q4 24
84.1%
1.2%
Q3 24
24.2%
0.4%
Q2 24
26.1%
0.5%
Q1 24
17.4%
0.9%
Cash Conversion
CHCT
CHCT
SYPR
SYPR
Q4 25
3.91×
Q3 25
7.76×
-0.34×
Q2 25
Q1 25
9.06×
Q4 24
32.14×
17.13×
Q3 24
7.92×
-12.21×
Q2 24
385.25×
Q1 24
3.45×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CHCT
CHCT

Segment breakdown not available.

SYPR
SYPR

Sypris Electronics$17.7M59%
Transferred At Point In Time$12.5M41%

Related Comparisons